Symposium Overview

The pace of discovery in rare brain disorders has never been faster. Precision genetics, genome editing, RNA modulation, and targeted delivery platforms are redefining what is possible in the brain. Yet the path from discovery to effective treatment remains complex, capital-intensive, and often siloed across disorders and sectors.

RareNet 2026 brings together leaders from academia, biotechnology, and patient advocacy to build a more integrated translational model for rare brain disorders. By bridging discovery science with therapeutic engineering and real-world implementation, the symposium will explore practical strategies to overcome current bottlenecks in translation to clinical development.

Additional Details & Registration Coming Soon